Abstract
Leucovorin is one of the several chemically active reduced derivatives of folic acid. It is used as an antidote to folic acid antagonist. Lecovorin calcium inj U.S.P. contains calcium folinate which belongs to a group of vitamins, used as an antidote to the harmful effects of Methotrexate (MTX) therapy. In this investigation, the modulatory effects exerted by the Leucovorin against MTX induced genotoxicity in mice by using Chromosomal Aberrations (CA) and sperm morphology assays were tested. Three different doses of Leucovorin were selected and tested for their modulatory activity on the genotoxicity exerted by 20 mg/kg of MTX. The results of the present study indicate a significant decrease in the frequency of CA and sperm head abnormalities suggesting that the Leucovorin modulates the MTX induced genotoxicity in a dose dependent manner and it reveals its antitoxic nature and suggests using along with chemotherapeutic agents in cancer chemotherapy. These findings provide the future directions for the research on design and development of possible modulatory drugs containing Leucovorin.
Keywords: Leucovorin, Genotoxicity, Chromosomal aberrations, Sperm head abnormalities.
Letters in Drug Design & Discovery
Title:Anticancer Studies of Leucovorin against Methotrexate Induced Genotoxicity in Swiss Albino Mice
Volume: 11 Issue: 1
Author(s): Chandra Sekhar Singh Bhaludra, Adharvana Chari Murugulla, Chakrapani Pullagummi, Ajay kumar Polkampally and Roja Rani Anupalli
Affiliation:
Keywords: Leucovorin, Genotoxicity, Chromosomal aberrations, Sperm head abnormalities.
Abstract: Leucovorin is one of the several chemically active reduced derivatives of folic acid. It is used as an antidote to folic acid antagonist. Lecovorin calcium inj U.S.P. contains calcium folinate which belongs to a group of vitamins, used as an antidote to the harmful effects of Methotrexate (MTX) therapy. In this investigation, the modulatory effects exerted by the Leucovorin against MTX induced genotoxicity in mice by using Chromosomal Aberrations (CA) and sperm morphology assays were tested. Three different doses of Leucovorin were selected and tested for their modulatory activity on the genotoxicity exerted by 20 mg/kg of MTX. The results of the present study indicate a significant decrease in the frequency of CA and sperm head abnormalities suggesting that the Leucovorin modulates the MTX induced genotoxicity in a dose dependent manner and it reveals its antitoxic nature and suggests using along with chemotherapeutic agents in cancer chemotherapy. These findings provide the future directions for the research on design and development of possible modulatory drugs containing Leucovorin.
Export Options
About this article
Cite this article as:
Bhaludra Sekhar Singh Chandra, Murugulla Chari Adharvana, Pullagummi Chakrapani, Polkampally kumar Ajay and Anupalli Rani Roja, Anticancer Studies of Leucovorin against Methotrexate Induced Genotoxicity in Swiss Albino Mice, Letters in Drug Design & Discovery 2014; 11(1) . https://dx.doi.org/10.2174/15701808113109990052
DOI https://dx.doi.org/10.2174/15701808113109990052 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Applications of FDG-PET/CT in Assessment of Vascular Infection and Inflammation
Current Molecular Imaging (Discontinued) Insight into the Medicinal Chemistry of EGFR and HER-2 Inhibitors
Current Medicinal Chemistry The Sphingolipid Rheostat: A Potential Target for Improving Pancreatic Islet Survival and Function
Endocrine, Metabolic & Immune Disorders - Drug Targets Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Biologically Active Agents
Current Medicinal Chemistry Wnt Signaling in Rhabdomyosarcoma – A Potential Targeted Therapy Option
Current Drug Targets Bioactive Polyphenols from Healthy Diets and Forest Biomass
Current Nutrition & Food Science RECKing MMP: Relevance of Reversion-inducing Cysteine-rich Protein with Kazal Motifs as a Prognostic Marker and Therapeutic Target for Cancer (A Review)
Anti-Cancer Agents in Medicinal Chemistry Regulation of Tumor Angiogenesis by the Immune System
Current Angiogenesis (Discontinued) Defining Cell Identity by Comprehensive Gene Expression Profiling
Current Medicinal Chemistry Separation of Ginseng Active Ingredients and their Roles in Cancer Metastasis Supplementary Therapy
Current Drug Metabolism Proteome Analysis of Formalin-Fixed Paraffin-Embedded Tissues from a Primary Gastric Melanoma and its Meningeal Metastasis: A Case Report
Current Topics in Medicinal Chemistry Synthetic Glycopeptides from the Mucin Family as Potential Tools in Cancer Immunotherapy
Current Cancer Drug Targets Perfusion Computed Tomography and its Application in Oncologic Practice
Current Molecular Imaging (Discontinued) Synthesis and Characterization of ROSA Dye - A Rhodamine B-type Fluorophore, Suitable for Bioconjugation and Fluorescence Studies in Live Cells
Protein & Peptide Letters Molecular Targets for Promoting Wound Healing in Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Current Management of Neonatal Liver Tumors
Current Pediatric Reviews The Contribution of Transcriptomics to Biomarker Development in Systemic Vasculitis and SLE
Current Pharmaceutical Design Peptide Sequence-Dominated Enzyme-Responsive Nanoplatform for Anticancer Drug Delivery
Current Topics in Medicinal Chemistry Identification and Characterization of SNP Mutation in Genes Related to Non-small Cell Lung Cancer
Current Signal Transduction Therapy The Novel RARβ Isoform (β 5) is a Potential Target of Retinoids in Breast Cancer
Current Cancer Drug Targets